Background: Heart failure is a complex and multifactorial disease that affects millions globally, posing significant challenges to healthcare systems.

Idiopathic epilepsy is the most common medical neurologic disorder of dogs and is reported to affect one in every 100 dogs.

Salubris Biotherapeutics, Inc. (SalubrisBio), a clinical-stage biotechnology company dedicated to discovering and developing ...

In the first 22 months of a mavacamten REMS program, few patients needed a temporary interruption in treatment for LVEF below 50%.

The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.

With the growing trend of heavier cattle and carcass weights, packers are seeing higher rates of bovine congestive heart ...

Mina Makar highlights AstraZeneca's commitment to advancing heart failure research and innovative therapies, addressing ...

Alleviant Medical announced today that it brought in $90 million to fund the second pivotal trial of its atrial shunt ...

"These findings reinforce the use of dapagliflozin, 10 mg, or other SGLT2 inhibitors when the therapeutic goal is to reduce ...

Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...

Much has changed since the 2013 document came out, with new information on pacing devices, techniques, and more.

Atrial fibrillation, or A-fib, is an irregular heart rhythm that increases a person's risk of stroke, heart failure and even ...